Loading
MH
Metro Healthcare Berhad Stock: price and insider trades · Malaysia
MY·Mcap MYR 210.5M
1 insider bought €13k of shares over the last 90 days, the latest filed 30 Sept 2026.
Metro Healthcare Berhad: what insiders have been doing
Metro Healthcare Berhad is a listed company. Filings by its managers are published through Bursa Malaysia (SC). 7 insiders have disclosed 10 filings since 18 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €13k, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €13k from Lim Wai Khong, disclosed on 30 September 2026, or 0.029% of market capitalisation. Those buying include 1 senior executive.
Compared with its exchange (344 companies, median 4 filings), a count of 10 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 1 purchase and no sales.
The latest purchase is recent: it was published 18 days ago, on 30 September 2026. Between a trade and the moment it shows up on Bursa Malaysia (SC), the median delay is 5 days. The shorter that gap, the sooner other investors can see what insiders have done.
Every figure here comes from the filings published by Bursa Malaysia (SC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€13,209
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleLim Wai Khong1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 10,066 of 24,148 companies
55.8
score / 100
Value47
Quality64
FCF yld3.6%
Earn yld2.8%
EV/EBITDA15.6x
ROE9.2%
Gross mgn38%
Net mgn12%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
MYR 0.22
Analyst consensus
Income statement
RevenueMYR 50.4M
Gross profitMYR 19M38% margin
EBITDAMYR 14.4M29% margin
Net incomeMYR 5.9M13.4% margin
Valuation
PER (trailing)21.5x
P/Book2.8x
Beta0.25
Balance sheet & cash
Market capMYR 210.5M
Total debtMYR 14.3M
Free Cash FlowMYR 7.6M
Debt / Equity24%
Profitability & ownership
ROE9.2%
ROA5.1%
% insiders91.9%
% institutions0.0%
Last declaration on 30 September 2026
Declarations10 total
300,000 shares@ MYR 0.210.029% mcap100.0% of flowOrdinary SharesBURSABURSA:bursa-my:3710870:1
Canonical exit: 28 Dec 2026 (T+90)
20,000 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688984:1
1,978,989 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688983:1
20,000 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688982:1
10,000 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688978:1
62,500 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688979:2
12,346,384 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688979:3
94,610,332 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688979:1
47,700,410 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688980:1
20,000 sharesWarrants 2026/2031BURSABURSA:bursa-my:3688981:1
10 of 10 declarations
About Metro Healthcare Berhad
Metro Healthcare Berhad is a company listed on the XKLS market, specializing in the healthcare sector. It offers various health-related services and products.
